Diagnostic Effectiveness of whole Body Diffusion- Weighted Magnetic Resonance Imaging in Focal and Diffuse Bone Marrow Involvement in Patients with Lymphoma

2017 ◽  
pp. 66-81 ◽  
Author(s):  
S. A. Kharuzhyk ◽  
E. A. Zhavrid ◽  
N. U. Sachivko

Objective:to compare diagnostic effectiveness of whole body  diffusion-weighted imaging (DWI), other magnetic resonance  imaging (MRI) pulse sequences and iliac wing trephine biopsy in the  diagnosis of focal and diffuse bone marrow (BM) involvement in patients with lymphoma.Materials and methods.Prospective study included 130 patients  with lymphoma who underwent whole-body MRI-DWI and iliac wing  trephine biopsy before treatment (64 (49,2%) men, 66 (50,8%)  women, middle age 43,3 ± 16,3 years, interval of 18–79 years).  Hodgkin's lymphoma (HL) was at 57 (44%) patients, non-Hodgkin  lymphomas (NHL) – at 73 (56%). Diagnostic effectiveness of T1- weighted images (T1-WI), STIR, DWI and FIESTA was analyzed. BM  apparent diffusion coefficient (ADC) values were measured.Results.BM involvement was found in 42 patients, including 9 with  HL and 33 with NHL. In HL, BM involvement was only focal. Diffuse  involvement occurred more often (64%) in the NHL as compared to  focal one. In focal involvement, all pulse sequences showed high  diagnostic sensitivity (90–100%), BM biopsy sensitivity was 33%  only. The proposed new criterion for the diagnosis of diffuse BM involvement in NHL – diffuse signal increase of the spine on DWI  above renal parenchyma – has the highest sensitivity (90%) compared to T1-WI and STIR (67%) and FIESTA (71%) (p < 0.05).  In NHL, the ADC value ≤0.575 • 10−3 mm2/s discrimi nates cases  of diffuse involvement and absence of BM involvement with a  sensitivity of 86% and a specificity of 68% (p < 0.0001). In HL, the  diffuse BM signal increase on DWI is not indicative of involvement.Conclusion.All pulse sequences showed high effectiveness in the  diagnosis of focal BM involvement in patients with lymphoma, iliac  wing biopsy effectiveness was low. The proposed new DWI criterion  for diagnosing diffuse BM involvement in NHL is the most sensitive  one. A new algorithm based on whole body MRI-DWI for the  diagnosis of BM involvement allows to reduce the need for BM biopsy without reducing the diagnostic effectiveness.

2020 ◽  
Vol 65 (4) ◽  
pp. 431-443
Author(s):  
N. S. Lutsik ◽  
L. P. Mendeleeva ◽  
M. V. Solovev ◽  
S. M. Kulikov ◽  
Yu. A. Chabaeva ◽  
...  

Introduction. Whole-body diffusion-weighted magnetic resonance imaging (MRI) is an informative method for bone marrow infiltration diagnosis in patients with multiple myeloma (MM) and post-monitoring in autologous haematopoietic stem cell transplantation (auto-HSCT).Aim: to study bone marrow lesions in MM patients using whole-body MRI prior to and after chemotherapy with subsequent auto-HSCT.Materials and methods. Forty patients with MM were included in a prospective study of whole-body MRI before and after high-dose chemotherapy with auto-HSCT. All patients had whole-body MRI prior to and at +100 day of auto-HSCT. Antitumour response was assessed after induction and at +100 day. The number and volume of bone marrow lesions prior to and at +100 day of auto-HSCT were determined, along with apparent diffusion coefficient (ADC) in the lesions.Results. We observed a significant reduction of 29 % in the number of lesions, 40 % — in their volume and 33 % — in ADC. A significant correlation was revealed between relative reduction in the number and volume of foci (r = 0.52, p = 0.0017). A correlation was found between relative reduction in the foci number and ADC (r = 0.47, p = 0.016). Patients with lesions > 7 cm3 in MRI data exhibited a lesser reduction in the foci number and volume and ADC values after auto-HSCT compared to patients with lesions < 7 cm3.Conclusion. Whole-body MRI with diffusion-weighted imaging and subsequent estimation of the number and volume of lesions and their ADC values prior to and after auto-HSCT add power to assessing antitumour response in MM patients with auto-HSCT.


2001 ◽  
Vol 05 (01) ◽  
pp. 035-042 ◽  
Author(s):  
Andrea Baur ◽  
Axel Stäbler ◽  
Armin Huber ◽  
Maximilian Reiser

2020 ◽  
pp. 028418512093837
Author(s):  
Sunay Sibel Karayol ◽  
Kudret Cem Karayol

Background The aim of this study is to investigate the role of diffusion-weighted imaging (DWI) in the differential diagnosis of sacroiliitis. Purpose To compare the sacroiliac magnetic resonance imaging (MRI) examinations of patients with suspected active sacroiliitis with patients with acute SpA MR findings and the DWI examinations of patients with acute brucella sacroiliitis, and thereby determine whether DWI can contribute to the differential diagnosis. Material and Methods A total of 84 patients were included in the study and were separated into three groups: group 1 (13 women, 6 men) comprised cases with brucella positive for sacroiliitis; group 2 (17 women, 19 men) comprised cases negative for brucella but with sacroiliitis; and group 3 (16 women, 13 men) comprised cases negative for brucella and sacroiliitis. Results The mean bone marrow apparent diffusion coefficient (ADC) values independently of edema were determined as 0.71 × 10−3 in sacroiliitis and brucella-positive patients, as 0.53 × 10−3 in brucella-negative and sacroiliitis-positive patients, and as 0.43 × 10−3 in the control group of brucella-negative sacroiliitis-negative patients. In the ADC measurements taken from areas of evident edema in patients with sacroiliitis, the mean values were 0.13 × 10−3 in the brucella-positive group and 0.12 × 10−3 in the brucella-negative group. Conclusion By adding DWI, which is a rapid MR sequence, to sacroiliac joint MR examination, normal bone marrow and bone marrow with sacroiliitis can be objectively differentiated with ADC measurements in addition to visual evaluation.


Sign in / Sign up

Export Citation Format

Share Document